The AACR remains fully committed to supporting publishing operations throughout this challenging time, while still remaining flexible and supportive of the author, reviewer, and editor communities that we serve. If you have any questions or concerns, please reach out to a member of the AACR publishing staff.
Please visit the COVID-19 & Cancer Resource Center where COVID-related content is freely available.
News from Cancer Discovery
- Mechanisms of KRAS Inhibitor Resistance Revealed
Patients who stop responding to adagrasib may develop secondary KRAS mutations, variety of other alterations. - Immunotherapy Activates Antitumor γ9δ2 T Cells
In a clinical trial, BNT3A antibody stimulated the unique lymphocytes and promoted their trafficking to tumors. - Genomic Differences by Race Emerge in Colorectal Cancer
Mutation patterns in early-onset disease vary among Black, white, and Asian/Pacific Islander patients. - TCR Bispecific Boosts Survival in Uveal Melanoma
Tebentafusp poised to become standard of care for metastatic eye cancer—but only for subset of patients. - NHL Progression Risk Cut with Copanlisib–Rituximab Combo
Benefit seen in wide range of indolent NHL subtypes when PI3K inhibitor added. - Oncolytic Herpes Virus Shrinks Pediatric Gliomas
Decades-old virotherapy “worth taking forward” to treat brain cancer.
Advertisement
Trending - Altmetric
No Altmetric data available.
